Table 1.
Clinical and demographic characteristics of the subjects with IGT at baseline
| Variables | Controls | Treated |
|---|---|---|
| Subjects | 8 | 9 |
| Female/Women | 5 (63) | 5 (56) |
| Male/Men | 3 (37) | 4 (44) |
| Age (years) | 72 ± 2 | 73 ± 2 |
| BMI (kg/m2) | 28.6 ± 1.9 | 25.7 ± 1.3 |
| Waist circumference (cm) | 0.9 ± 0.1 | 0.9 ± 0.09 |
| Smoking | ||
| No | 8 (100) | 6 (67) |
| Previously | 0 (0) | 3 (33) |
| Present | 0 (0) | 0 (0) |
| Blood pressure | ||
| Systolic (mmHg) | 122 ± 16.7 | 140.5 ± 4,7 |
| Diastolic (mmHg) | 80.0 ± 2.6 | 82.0 ± 2.8 |
| Fasting-glucose (mmol/l) | 6.7 ± 0.4 | 6.0 ± 0.3 |
| Fasting-insulin (mlE/l) | 11.1 ± 2.0 | 9.8 ± 2.1 |
| HbA1c (mmol/mol) | 40.1 ± 2.4 | 39.6 ± 1.3 |
| Cholesterol (mmol/l) | 4.5 ± 0.2 | 4.9 ± 0.4 |
| LDL Cholesterol (mmol/l) | 2.7 ± 0.2 | 3.2 ± 0.4 |
| HDL Cholesterol (mmol/l) | 1.5 ± 0.1 | 1.4 ± 0.1 |
| Triglycerides (mmol/l) | 1.1 ± 0.1 | 1.1 ± 0.1 |
Gender and smoking-related values are given as percentages, all other values are reported as the mean ± SD.
The groups did not differ for any variable, p<0.05.